Janiszewska-Bil Dominika, Grabarek Beniamin Oskar, Lyssek-Boroń Anita, Kiełbasińska Aleksandra, Kuraszewska Bernadeta, Wylęgała Edward, Krysik Katarzyna
Department of Ophthalmology, Trauma Centre, St. Barbara Hospital, 41-200 Sosnowiec, Poland.
Optegra Clinic in Katowice, 40-101 Katowice, Poland.
Biomedicines. 2024 Oct 9;12(10):2289. doi: 10.3390/biomedicines12102289.
BACKGROUND/OBJECTIVES: In this study, we aimed to analyze the changes in the expression profiles of selected messenger RNAs (mRNAs) and their encoded proteins in the tears of patients undergoing photorefractive keratectomy (PRK), femtosecond-assisted laser in situ keratomileusis (FS-LASIK), and small-incision lenticule extraction (SMILE) procedures.
A total of 120 patients were divided into three groups based on the laser vision correction (LVC) procedure: PRK, FS-LASIK, or SMILE. Tear samples were collected preoperatively and at 1, 7, 30, and 180 days postoperatively. The expression levels of selected messenger RNAs (mRNAs) and proteins were analyzed by using reverse transcription quantitative polymerase chain reaction (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA), respectively.
PRK and FS-LASIK elicited significantly stronger biological responses than SMILE. Interleukin-15 () expression increased notably in the PRK and FS-LASIK groups, with mRNA levels reaching fold changes of 4.65 ± 0.65 and 4.99 ± 0.28, respectively, on day 1, compared with only 2.09 ± 0.23 in the SMILE group. Vascular endothelial growth factor A () levels were also elevated in the PRK (2.98 ± 0.23 fold change) and FS-LASIK groups (3.45 ± 1.09 fold change) on day 1, while the SMILE group showed minimal fluctuations. The protein concentration analysis based on the ELISA confirmed these trends, with IL-15 levels peaking at 54.2 ± 2.5 pg/mL in the PRK group and 52.8 ± 3.1 pg/mL in the FS-LASIK group, compared with 32.4 ± 1.9 pg/mL in the SMILE group on day 1. Similarly, VEGFA protein concentrations were the highest in the PRK (72.4 ± 4.1 pg/mL) and FS-LASIK patients (69.5 ± 3.8 pg/mL) on day 1 but remained low in the SMILE patients (45.6 ± 2.3 pg/mL). By day 180, gene expression and protein levels in all groups had stabilized, returning to near-preoperative values.
PRK and FS-LASIK induced more pronounced molecular and protein-level changes during corneal wound healing than the less invasive SMILE procedure, indicating stronger biological responses. These findings suggest that tailored postoperative care based on the specific procedure could optimize healing and patient outcomes. However, further research with larger sample sizes and longer follow-ups is needed to confirm these observations and develop personalized treatment strategies.
背景/目的:在本研究中,我们旨在分析接受准分子激光原位角膜磨镶术(PRK)、飞秒激光制瓣准分子原位角膜磨镶术(FS-LASIK)和小切口基质透镜切除术(SMILE)的患者泪液中选定信使核糖核酸(mRNA)及其编码蛋白的表达谱变化。
根据激光视力矫正(LVC)手术将120例患者分为三组:PRK组、FS-LASIK组或SMILE组。术前及术后1天、7天、30天和180天采集泪液样本。分别采用逆转录定量聚合酶链反应(RT-qPCR)和酶联免疫吸附测定(ELISA)分析选定mRNA和蛋白的表达水平。
PRK和FS-LASIK引起的生物学反应明显强于SMILE。白细胞介素-15(IL-15)表达在PRK组和FS-LASIK组显著增加,第1天时mRNA水平的倍数变化分别达到4.65±0.65和4.99±0.28,而SMILE组仅为2.09±0.23。血管内皮生长因子A(VEGFA)水平在第1天时在PRK组(2.98±0.23倍变化)和FS-LASIK组(3.45±1.09倍变化)也升高,而SMILE组波动最小。基于ELISA的蛋白浓度分析证实了这些趋势,IL-15水平在第1天时在PRK组达到峰值54.2±2.5 pg/mL,在FS-LASIK组为52.8±3.1 pg/mL,而SMILE组为32.4±1.9 pg/mL。同样,VEGFA蛋白浓度在第1天时在PRK患者(72.4±4.1 pg/mL)和FS-LASIK患者(69.5±3.8 pg/mL)中最高,但在SMILE患者中保持较低水平(45.6±2.3 pg/mL)。到第180天时,所有组的基因表达和蛋白水平均已稳定,恢复到接近术前值。
与侵入性较小的SMILE手术相比,PRK和FS-LASIK在角膜伤口愈合过程中诱导了更明显的分子和蛋白水平变化,表明生物学反应更强。这些发现表明,根据具体手术制定的术后护理可以优化愈合和患者预后。然而,需要更大样本量和更长随访时间的进一步研究来证实这些观察结果并制定个性化治疗策略。